Cepheid has launched its next-generation Xpert Flu test for the GeneXpert system, a CE/IVD-marked product offering on-demand testing for triage, outbreaks, emergencies and high-risk patient management.
In any healthcare environment, rapid and accurate diagnosis of influenza is vital for effective clinical management and infection control. Cepheid’s next-generation Xpert Flu is the only molecular diagnostic test capable of providing on-demand results in just over an hour. With faster turnaround times for improved workflows, plus wider coverage, it enables real-time determination of influenza A and B infection, as well as the identification of 2009 H1N1, maximising medical decision-making.
www.cepheid.com/product-catalog/clinical-ivd-tests/xpert-flu